Akums combines two potent diabetes medicines for enhanced treatment efficacy: Our Bureau, Bengaluru Tuesday, February 4, 2025, 15:30 Hrs [IST] Akums Drugs and Pharmaceuticals, a l ...

THESE DRUGS COULD POSSIBLY PREVENT HEART ATTACK AND STROKE. THE RESULTS ARE PROMISING FOR HEART PATIENTS.. THESE MEDICATIONS ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

This dual action—addressing blood sugar while simultaneously protecting the heart—is one of the key reasons these medications are so transformative in diabetes management. Recent research ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.